Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Amplicon Sequencing-Based Noninvasive Fetal Genotyping for RHD-Positive D Antigen-Negative Alleles.

Takahashi K, Migita O, Sasaki A, Nasu M, Kawashima A, Sekizawa A, Sato T, Ito Y, Sago H, Okamoto A, Nakabayashi K, Hata K.

Clin Chem. 2019 Sep 5. pii: clinchem.2019.307074. doi: 10.1373/clinchem.2019.307074. [Epub ahead of print]

PMID:
31488553
2.

Decline in maternal death due to obstetric haemorrhage between 2010 and 2017 in Japan.

Hasegawa J, Katsuragi S, Tanaka H, Kurasaki A, Nakamura M, Murakoshi T, Nakata M, Kanayama N, Sekizawa A, Isamu I, Kinoshita K, Ikeda T.

Sci Rep. 2019 Jul 30;9(1):11026. doi: 10.1038/s41598-019-47378-z.

3.

Spontaneous regression of quiescent gestational trophoblastic disease after pregnancy: a case report.

Okada Y, Miyamoto S, Mimura T, Ishikawa T, Sekizawa A, Matsumoto K.

BMC Womens Health. 2019 Jul 23;19(1):101. doi: 10.1186/s12905-019-0794-2.

4.

Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial.

Maki S, Tanaka H, Tsuji M, Furuhashi F, Magawa S, Kaneda MK, Nii M, Tanaka K, Kondo E, Tamaru S, Ogura T, Nishimura Y, Endoh M, Kimura T, Kotani T, Sekizawa A, Ikeda T.

J Clin Med. 2019 Jun 15;8(6). pii: E856. doi: 10.3390/jcm8060856.

5.

Modified laparoscopic cervicoisthmic cerclage in early pregnancy for refractory cervical incompetence: A case report.

Seo K, Dohi S, Ishikawa T, Ichizuka K, Sekizawa A, Nagatsuka M.

J Obstet Gynaecol Res. 2019 Aug;45(8):1597-1602. doi: 10.1111/jog.14004. Epub 2019 May 28.

PMID:
31137082
6.

Differences in perinatal outcomes according to forming period of single umbilical cord in singleton pregnancy.

Nakamura M, Oba T, Takita H, Tokunaka M, Arakaki T, Goto M, Koyano M, Hamada S, Matsuoka R, Sekizawa A.

Prenat Diagn. 2019 Jul;39(8):588-594. doi: 10.1002/pd.5471. Epub 2019 Jun 6.

PMID:
31063270
7.

Analysis of preventability of malignancy-related maternal death from the nationwide registration system of maternal deaths in Japan.

Katsuragi S, Tanaka H, Hasegawa J, Kanayama N, Nakata M, Murakoshi T, Osato K, Nakamura M, Tanaka K, Sekizawa A, Ishiwata I, Yamamoto Y, Wakasa T, Takeuchi M, Yoshimatsu J, Ikeda T.

J Matern Fetal Neonatal Med. 2019 May 2:1-7. doi: 10.1080/14767058.2019.1609930. [Epub ahead of print]

PMID:
30999803
8.

Whole-Genome Analysis of Human Papillomavirus Type 16 Prevalent in Japanese Women with or without Cervical Lesions.

Hirose Y, Onuki M, Tenjimbayashi Y, Yamaguchi-Naka M, Mori S, Tasaka N, Satoh T, Morisada T, Iwata T, Kiyono T, Mimura T, Sekizawa A, Matsumoto K, Kukimoto I.

Viruses. 2019 Apr 16;11(4). pii: E350. doi: 10.3390/v11040350.

9.

Racial Disparities in Response to a US Food and Drug Administration Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma.

Matsushita T, Sekizawa A, Jacobs LK.

J Minim Invasive Gynecol. 2019 Mar 30. pii: S1553-4650(19)30144-X. doi: 10.1016/j.jmig.2019.03.019. [Epub ahead of print]

PMID:
30936031
10.

Usefulness of color Doppler mode for fetal cardiac ultrasound screening in the second trimester: a study at a single perinatal center.

Takita H, Matsuoka R, Tokunaka M, Goto M, Arakaki T, Kawashima A, Oba T, Nakamura M, Sekizawa A.

J Matern Fetal Neonatal Med. 2019 Mar 5:1-4. doi: 10.1080/14767058.2019.1583731. [Epub ahead of print]

PMID:
30835602
11.

Current status of Neisseria gonorrhoeae cervicitis in pregnant women in Japan.

Suzuki S, Hoshi SI, Sekizawa A, Sagara Y, Tanaka M, Kinoshita K, Kitamura T.

PLoS One. 2019 Feb 7;14(2):e0211595. doi: 10.1371/journal.pone.0211595. eCollection 2019.

12.

Classification of factors involved in nonreportable results of noninvasive prenatal testing (NIPT) and prediction of success rate of second NIPT.

Suzumori N, Sekizawa A, Takeda E, Samura O, Sasaki A, Akaishi R, Wada S, Hamanoue H, Hirahara F, Kuriki H, Sawai H, Nakamura H, Yamada T, Miura K, Masuzaki H, Yamashita T, Kamei Y, Namba A, Murotsuki J, Tanemoto T, Fukushima A, Haino K, Tairaku S, Matsubara K, Maeda K, Kaji T, Ogawa M, Osada H, Nishizawa H, Okamoto Y, Kanagawa T, Kakigano A, Endo M, Kitagawa M, Ogawa M, Izumi S, Katagiri Y, Takeshita N, Kasai Y, Naruse K, Neki R, Masuyama H, Hyodo M, Kawano Y, Ohba T, Ichizuka K, Nagamatsu T, Watanabe A, Nishikawa N, Hamajima N, Shirato N, Yotsumoto J, Nishiyama M, Koide K, Hirose T, Sago H.

Prenat Diagn. 2019 Jan;39(2):100-106. doi: 10.1002/pd.5408. Epub 2019 Jan 10.

PMID:
30586157
13.

TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial.

Umekawa T, Maki S, Kubo M, Tanaka H, Nii M, Tanaka K, Osato K, Kamimoto Y, Tamaru S, Ogura T, Nishimura Y, Kodera M, Minamide C, Nishikawa M, Endoh M, Kimura T, Kotani T, Nakamura M, Sekizawa A, Ikeda T; TADAFER study group.

BMJ Open. 2018 Oct 30;8(10):e020948. doi: 10.1136/bmjopen-2017-020948.

14.

The most common causative bacteria in maternal sepsis-related deaths in Japan were group A Streptococcus: A nationwide survey.

Tanaka H, Katsuragi S, Hasegawa J, Tanaka K, Osato K, Nakata M, Murakoshi T, Sekizawa A, Kanayama N, Ishiwata I, Ikeda T.

J Infect Chemother. 2019 Jan;25(1):41-44. doi: 10.1016/j.jiac.2018.10.004. Epub 2018 Oct 28.

PMID:
30377069
15.

Strategy to ensure a sufficient supply of cord blood stem cells in Japan.

Suzuki S, Sekizawa A, Tanaka M, Okai T, Kinoshita K.

Transfus Med. 2018 Dec;28(6):461. doi: 10.1111/tme.12567. Epub 2018 Oct 28. No abstract available.

PMID:
30370645
16.

Publisher Correction: Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration.

Nakabayashi M, Kawashima A, Yasuhara R, Hayakawa Y, Miyamoto S, Iizuka C, Sekizawa A.

Sci Rep. 2018 Oct 23;8(1):15883. doi: 10.1038/s41598-018-34168-2.

17.

Distribution of PAPP-A and total hCG between 11 and 13 weeks of gestation in Japanese pregnant women.

Hasegawa J, Wada S, Kasamatsu A, Nakamura M, Hamanoue H, Iwata E, Murotsuki J, Nagai R, Tateishi Y, Sunami R, Tajima A, Murata S, Matsubara K, Nakata M, Kondo A, Nishiyama M, Sasaki A, Sekizawa A, Sago H, Kamei Y; Study group for first trimester Combined Test (FCTG).

J Matern Fetal Neonatal Med. 2018 Nov 28:1-6. doi: 10.1080/14767058.2018.1536737. [Epub ahead of print]

PMID:
30318933
18.

Correction: Nationwide survey for current clinical status of amniocentesis and maternal serum marker test in Japan.

Miyake H, Yamada S, Fujii Y, Sawai H, Arimori N, Yamanouchi Y, Ozasa Y, Kanai M, Sago H, Sekizawa A, Takada F, Masuzaki H, Matsubara Y, Hirahara F, Kugu K.

J Hum Genet. 2018 Nov;63(11):1195. doi: 10.1038/s10038-018-0500-5. Epub 2018 Aug 23.

PMID:
30140059
19.

Treatment of twin-reversed arterial perfusion sequence using high-intensity focused ultrasound.

Seo K, Ichizuka K, Okai T, Dohi S, Nakamura M, Hasegawa J, Matsuoka R, Yoshizawa S, Umemura SI, Nagatsuka M, Sekizawa A.

Ultrasound Obstet Gynecol. 2019 Jul;54(1):128-134. doi: 10.1002/uog.20101.

PMID:
30136326
20.

Relationship between reproductive medicine for women with severe complications and maternal death in Japan.

Tanaka H, Katsuragi S, Hasegawa J, Osato K, Nakata M, Murakoshi T, Sekizawa A, Kanayama N, Ishiwata I, Ikeda T.

J Obstet Gynaecol Res. 2019 Jan;45(1):164-167. doi: 10.1111/jog.13787. Epub 2018 Aug 16.

PMID:
30117233
21.

Correction: Maternal age-specific risk for trisomy 21 based on the clinical performance of NIPT and empirically derived NIPT age-specific positive and negative predictive values in Japan.

Yamada T, Sekizawa A, Fujii Y, Hirose T, Samura O, Suzumori N, Miura K, Sawai H, Hirahara F, Murotsuki J, Kamei Y, Sago H; Japan NIPT consortium*.

J Hum Genet. 2018 Oct;63(10):1097-1098. doi: 10.1038/s10038-018-0486-z.

PMID:
30069028
22.

Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration.

Nakabayashi M, Kawashima A, Yasuhara R, Hayakawa Y, Miyamoto S, Iizuka C, Sekizawa A.

Sci Rep. 2018 Jul 25;8(1):11205. doi: 10.1038/s41598-018-29381-y. Erratum in: Sci Rep. 2018 Oct 23;8(1):15883.

23.

First-trimester measurements of the three-dimensional ultrasound placental volume and uterine artery Doppler in early- and late-onset fetal growth restriction.

Arakaki T, Hasegawa J, Nakamura M, Takita H, Hamada S, Oba T, Matsuoka R, Sekizawa A.

J Matern Fetal Neonatal Med. 2018 Sep 19:1-6. doi: 10.1080/14767058.2018.1497601. [Epub ahead of print]

PMID:
29973102
24.

Maternal age-specific risk for trisomy 21 based on the clinical performance of NIPT and empirically derived NIPT age-specific positive and negative predictive values in Japan.

Yamada T, Sekizawa A, Fujii Y, Hirose T, Samura O, Suzumori N, Miura K, Sawai H, Hirahara F, Murotsuki J, Kamei Y, Sago H; Japan NIPT consortium*.

J Hum Genet. 2018 Oct;63(10):1035-1040. doi: 10.1038/s10038-018-0453-8. Epub 2018 May 30. Erratum in: J Hum Genet. 2018 Aug 1;:.

PMID:
29849041
25.

Analysis of preventability of hypertensive disorder in pregnancy-related maternal death using the nationwide registration system of maternal deaths in Japan.

Katsuragi S, Tanaka H, Hasegawa J, Nakamura M, Kanayama N, Nakata M, Murakoshi T, Yoshimatsu J, Osato K, Tanaka K, Sekizawa A, Ishiwata I, Ikeda T; Maternal Death Exploratory Committee in Japan and Japan Association of Obstetricians and Gynecologists.

J Matern Fetal Neonatal Med. 2019 Oct;32(20):3420-3426. doi: 10.1080/14767058.2018.1465549. Epub 2018 Apr 26.

PMID:
29699420
26.

The inferior vena cava diameter is a useful ultrasound finding for predicting postpartum blood loss.

Oba T, Koyano M, Hasegawa J, Takita H, Arakaki T, Nakamura M, Sekizawa A.

J Matern Fetal Neonatal Med. 2019 Oct;32(19):3251-3254. doi: 10.1080/14767058.2018.1462321. Epub 2018 Apr 18.

PMID:
29621917
27.

Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy.

Suzumori N, Sekizawa A, Ebara T, Samura O, Sasaki A, Akaishi R, Wada S, Hamanoue H, Hirahara F, Izumi H, Sawai H, Nakamura H, Yamada T, Miura K, Masuzaki H, Yamashita T, Okai T, Kamei Y, Namba A, Murotsuki J, Tanemoto T, Fukushima A, Haino K, Tairaku S, Matsubara K, Maeda K, Kaji T, Ogawa M, Osada H, Nishizawa H, Okamoto Y, Kanagawa T, Kakigano A, Kitagawa M, Ogawa M, Izumi S, Katagiri Y, Takeshita N, Kasai Y, Naruse K, Neki R, Masuyama H, Hyodo M, Kawano Y, Ohba T, Ichizuka K, Nagamatsu T, Watanabe A, Shirato N, Yotsumoto J, Nishiyama M, Hirose T, Sago H.

Eur J Obstet Gynecol Reprod Biol. 2018 May;224:165-169. doi: 10.1016/j.ejogrb.2018.03.048. Epub 2018 Mar 26.

PMID:
29605711
28.

Within-Host Variations of Human Papillomavirus Reveal APOBEC Signature Mutagenesis in the Viral Genome.

Hirose Y, Onuki M, Tenjimbayashi Y, Mori S, Ishii Y, Takeuchi T, Tasaka N, Satoh T, Morisada T, Iwata T, Miyamoto S, Matsumoto K, Sekizawa A, Kukimoto I.

J Virol. 2018 May 29;92(12). pii: e00017-18. doi: 10.1128/JVI.00017-18. Print 2018 Jun 15.

29.

Three-dimensional ultrasound imaging of intra-abdominal cervical-isthmus cerclage.

Ichizuka K, Seo K, Dohi S, Ishikawa T, Sekizawa A, Nagatsuka M.

Ultrasound Obstet Gynecol. 2018 May;51(5):704-705. doi: 10.1002/uog.19052. No abstract available.

30.

A systematic review of massive transfusion protocol in obstetrics.

Tanaka H, Matsunaga S, Yamashita T, Okutomi T, Sakurai A, Sekizawa A, Hasegawa J, Terui K, Miyake Y, Murotsuki J, Ikeda T.

Taiwan J Obstet Gynecol. 2017 Dec;56(6):715-718. doi: 10.1016/j.tjog.2017.10.001.

31.

Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study.

Shimada K, Matsumoto K, Mimura T, Ishikawa T, Munechika J, Ohgiya Y, Kushima M, Hirose Y, Asami Y, Iitsuka C, Miyamoto S, Onuki M, Tsunoda H, Matsuoka R, Ichizuka K, Sekizawa A.

Int J Clin Oncol. 2018 Jun;23(3):514-521. doi: 10.1007/s10147-017-1222-y. Epub 2017 Dec 13.

PMID:
29236181
32.

CT features for diagnosing acute torsion of uterine subserosal leiomyoma.

Ohgiya Y, Seino N, Miyamoto S, Takeyama N, Hatano K, Munechika J, Ishizuka K, Hirose M, Ohike N, Hashimoto T, Sekizawa A, Gokan T.

Jpn J Radiol. 2018 Mar;36(3):209-214. doi: 10.1007/s11604-017-0712-1. Epub 2017 Dec 9.

PMID:
29224115
33.

Hypertensive disorders of pregnancy: a strong risk factor for subsequent hypertension 5 years after delivery.

Mito A, Arata N, Qiu D, Sakamoto N, Murashima A, Ichihara A, Matsuoka R, Sekizawa A, Ohya Y, Kitagawa M.

Hypertens Res. 2018 Feb;41(2):141-146. doi: 10.1038/hr.2017.100. Epub 2017 Nov 2.

PMID:
29093561
34.

Maternal deaths in Japan due to abnormally invasive placenta.

Hasegawa J, Tanaka H, Katsuragi S, Sekizawa A, Ishiwata I, Ikeda T; Maternal Death Exploratory Committee in Japan and the Japan Association of Obstetricians and Gynecologists.

Int J Gynaecol Obstet. 2018 Mar;140(3):375-376. doi: 10.1002/ijgo.12368. Epub 2017 Nov 14. No abstract available.

PMID:
29080305
35.

Response to 'Silent uterine rupture occluded by intestinal adhesions following laparoscopic myomectomy: A case report': Do some remain permanently silent?

Arakaki T, Hasegawa J, Fukutani R, Sekizawa A.

J Obstet Gynaecol Res. 2017 Dec;43(12):1889. doi: 10.1111/jog.13488. Epub 2017 Oct 13. No abstract available.

PMID:
29027323
36.

Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer.

Tenjimbayashi Y, Onuki M, Hirose Y, Mori S, Ishii Y, Takeuchi T, Tasaka N, Satoh T, Morisada T, Iwata T, Miyamoto S, Matsumoto K, Sekizawa A, Kukimoto I.

Infect Agent Cancer. 2017 Aug 4;12:44. doi: 10.1186/s13027-017-0155-4. eCollection 2017.

37.

Coronary perfusion pressure and compression quality in maternal cardiopulmonary resuscitation in supine and left-lateral tilt positions: A prospective, crossover study using mannequins and swine models.

Dohi S, Ichizuka K, Matsuoka R, Seo K, Nagatsuka M, Sekizawa A.

Eur J Obstet Gynecol Reprod Biol. 2017 Sep;216:98-103. doi: 10.1016/j.ejogrb.2017.07.019. Epub 2017 Jul 16.

38.

A three-step evaluation for safer curettage treatment of cesarean scar pregnancy.

Matsushita T, Takenaka S, Nakabayashi M, Ogawa K, Sekizawa A.

Gynecol Minim Invasive Ther. 2017 Jul-Sep;6(3):132-134. doi: 10.1016/j.gmit.2017.02.003. Epub 2017 Mar 15.

39.

Intraspecific variations in responses to ocean acidification in two branching coral species.

Sekizawa A, Uechi H, Iguchi A, Nakamura T, Kumagai NH, Suzuki A, Sakai K, Nojiri Y.

Mar Pollut Bull. 2017 Sep 15;122(1-2):282-287. doi: 10.1016/j.marpolbul.2017.06.061. Epub 2017 Jun 24.

PMID:
28655461
40.

Silent uterine rupture occluded by intestinal adhesions following laparoscopic myomectomy: A case report.

Fukutani R, Hasegawa J, Arakaki T, Oba T, Nakamura M, Sekizawa A.

J Obstet Gynaecol Res. 2017 Jul;43(7):1209-1211. doi: 10.1111/jog.13339. Epub 2017 Jun 14.

PMID:
28612938
41.

Analysis of preventability of stroke-related maternal death from the nationwide registration system of maternal deaths in Japan.

Katsuragi S, Tanaka H, Hasegawa J, Nakamura M, Kanayama N, Nakata M, Murakoshi T, Yoshimatsu J, Osato K, Tanaka K, Sekizawa A, Ishiwata I, Ikeda T; ; on behalf of the Maternal Death Exploratory Committee in Japan and Japan Association of Obstetricians and Gynecologists.

J Matern Fetal Neonatal Med. 2018 Aug;31(16):2097-2104. doi: 10.1080/14767058.2017.1336222. Epub 2017 Jun 14.

PMID:
28610468
42.

Current status of non-invasive prenatal testing in Japan.

Samura O, Sekizawa A, Suzumori N, Sasaki A, Wada S, Hamanoue H, Hirahara F, Sawai H, Nakamura H, Yamada T, Miura K, Masuzaki H, Nakayama S, Okai T, Kamei Y, Namba A, Murotsuki J, Tanemoto T, Fukushima A, Haino K, Tairaku S, Matsubara K, Maeda K, Kaji T, Ogawa M, Osada H, Nishizawa H, Okamoto Y, Kanagawa T, Kakigano A, Kitagawa M, Ogawa M, Izumi S, Katagiri Y, Takeshita N, Kasai Y, Naruse K, Neki R, Masuyama H, Hyodo M, Kawano Y, Ohba T, Ichizuka K, Kido Y, Fukao T, Miharu N, Nagamatsu T, Watanabe A, Hamajima N, Hirose M, Sanui A, Shirato N, Yotsumoto J, Nishiyama M, Hirose T, Sago H.

J Obstet Gynaecol Res. 2017 Aug;43(8):1245-1255. doi: 10.1111/jog.13373. Epub 2017 Jun 6.

PMID:
28586143
43.

Early-onset primary peritoneal carcinoma from atypical cells after risk-reducing salpingo-oophorectomy for BRCA2 mutation carrier: a case report.

Shimizu H, Ishikawa T, Iitsuka C, Homma M, Takimoto M, Sekizawa A.

Int Cancer Conf J. 2017 Mar 21;6(3):104-108. doi: 10.1007/s13691-017-0287-9. eCollection 2017 Jul.

44.

Causes of intrauterine fetal death are changing in recent years.

Takita H, Hasegawa J, Nakamura M, Arakaki T, Oba T, Matsuoka R, Sekizawa A.

J Perinat Med. 2018 Jan 26;46(1):97-101. doi: 10.1515/jpm-2016-0337.

PMID:
28236631
45.

Analysis of maternal death autopsies from the nationwide registration system of maternal deaths in Japan.

Hasegawa J, Wakasa T, Matsumoto H, Takeuchi M, Kanayama N, Tanaka H, Katsuragi S, Nakata M, Murakoshi T, Osato K, Nakamura M, Sekizawa A, Ishiwata I, Ikeda T; Maternal Death Exploratory Committee in Japan and Japan Association of Obstetricians and Gynecologists.

J Matern Fetal Neonatal Med. 2018 Feb;31(3):333-338. doi: 10.1080/14767058.2017.1285890. Epub 2017 Feb 14.

PMID:
28110592
46.

Outcomes in the absence of the ductus venosus diagnosed in the first trimester.

Takita H, Hasegawa J, Arakaki T, Hamada S, Tokunaka M, Nakamura M, Matsuoka R, Sekizawa A.

J Matern Fetal Neonatal Med. 2018 Jan;31(2):253-257. doi: 10.1080/14767058.2017.1281241. Epub 2017 Jun 18.

PMID:
28076990
47.

Value of fibrinogen in cases of maternal death related to amniotic fluid embolism.

Tanaka H, Katsuragi S, Osato K, Hasegawa J, Nakata M, Murakoshi T, Yoshimatsu J, Sekizawa A, Kanayama N, Ishiwata I, Ikeda T.

J Matern Fetal Neonatal Med. 2017 Dec;30(24):2940-2943. doi: 10.1080/14767058.2016.1269166. Epub 2017 Jan 12.

PMID:
27921446
48.

Current status of syphilis in pregnant women in Japan.

Suzuki S, Sekizawa A, Tanaka M, Okai T, Kinoshita K, Kitamura T.

J Matern Fetal Neonatal Med. 2017 Dec;30(23):2881-2883. doi: 10.1080/14767058.2016.1266477. Epub 2016 Dec 14.

PMID:
27894194
49.

Efficacy of transfusion with fresh-frozen plasma:red blood cell concentrate ratio of 1 or more for amniotic fluid embolism with coagulopathy: a case-control study.

Tanaka H, Katsuragi S, Osato K, Hasegawa J, Nakata M, Murakoshi T, Yoshimatsu J, Sekizawa A, Kanayama N, Ishiwata I, Ikeda T.

Transfusion. 2016 Dec;56(12):3042-3046. doi: 10.1111/trf.13856. Epub 2016 Nov 2.

PMID:
27805263
50.

Nationwide survey for current clinical status of amniocentesis and maternal serum marker test in Japan.

Miyake H, Yamada S, Fujii Y, Sawai H, Arimori N, Yamanouchi Y, Ozasa Y, Kanai M, Sago H, Sekizawa A, Takada F, Masuzaki H, Matsubara Y, Hirahara F, Kugu K.

J Hum Genet. 2016 Oct;61(10):879-884. doi: 10.1038/jhg.2016.67. Epub 2016 Jun 30. Erratum in: J Hum Genet. 2018 Nov;63(11):1195.

PMID:
27357425

Supplemental Content

Loading ...
Support Center